MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the ...
Shanghai Fosun Pharmaceutical has announced that its subsidiary, Zhejiang Xinghao Pengbo Pharmaceutical, has launched a Phase II clinical trial in China for XH-S003, a small molec ...
Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.
A new model utilizing simple anthropometric measurements provided a viable alternative to bioimpedance for assessing body fat ...
Nearly 10% of people live with chronic kidney disease—in other words, their kidneys can't adequately filter waste from their ...
COVID-19 infection is associated with accelerated decline in kidney function, especially after hospitalization.
“Even in individuals who had not yet developed kidney disease, we could see that kidney function was linked to brain atrophy.
The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free ...
The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...
Empagliflozin led to promising weight loss outcomes in patients with prediabetes and diabetes, with the results being more prominent in men than in women.
It was discovered that Teddy's left kidney was the size of that of an 18-month-old and his right is close to failure - he ...
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney <a target=_blank href= ...